The Pharmaceutical Intellectual Property and Competition Law Review

The Pharmaceutical Intellectual Property and Competition Law Review Available in print versions

The Pharmaceutical Intellectual Property and Competition Law Review
Edition 2

Editors:

The Pharmaceutical Intellectual Property and Competition Law Review provides a practical overview of pharmaceutical intellectual property issues, including patent linkage and exclusivities, and related competition concerns. With a focus on recent developments, it is a useful tool for managing global risks in this area – analysing the key elements of the relevant legal and regulatory regimes across major jurisdictions worldwide.

Overview

The Pharmaceutical Intellectual Property and Competition Law Review: Editor's Preface

Jurisdictions

The Pharmaceutical Intellectual Property and Competition Law Review: Australia

The Pharmaceutical Intellectual Property and Competition Law Review: Brazil

The Pharmaceutical Intellectual Property and Competition Law Review: Canada

The Pharmaceutical Intellectual Property and Competition Law Review: France

The Pharmaceutical Intellectual Property and Competition Law Review: Hungary

The Pharmaceutical Intellectual Property and Competition Law Review: Japan

The Pharmaceutical Intellectual Property and Competition Law Review: Malaysia

The Pharmaceutical Intellectual Property and Competition Law Review: Poland

The Pharmaceutical Intellectual Property and Competition Law Review: Portugal

The Pharmaceutical Intellectual Property and Competition Law Review: Russia

The Pharmaceutical Intellectual Property and Competition Law Review: South Korea

The Pharmaceutical Intellectual Property and Competition Law Review: Spain

The Pharmaceutical Intellectual Property and Competition Law Review: USA

The Pharmaceutical Intellectual Property and Competition Law Review: United Kingdom

Get unlimited access to all The Law Reviews content